Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease - Report - MDSpire

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease

  • By

  • Haitao Chu

  • Xin Song

  • Chang Liu

  • Tianjiao Ma

  • Wanlin Cui

  • June 9, 2026

  • 0 min

Share

Clinical Report: The Role of Gut Microbial Bile Salt Hydrolase in Regulating Digestive Balance and Disease States

Overview

Expand on the specific mechanisms by which BSH dysregulation contributes to each disease.

Background

Bile acids are essential for lipid absorption and play a significant role in regulating metabolic and immune pathways. The gut microbiota, through enzymes like BSH, modulates bile acid composition, impacting host metabolism and immune responses. Understanding BSH's functions and its implications in disease states is crucial for developing targeted therapies.

Data Highlights

Incorporate qualitative findings or insights from the source to provide context.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the source.

Clinical Implications

Clinicians should consider the role of BSH in gut health and its potential as a therapeutic target in digestive diseases. Strategies that modulate BSH activity could enhance treatment outcomes for conditions like IBD and MASLD.

Conclusion

Bile salt hydrolase serves as a pivotal link between gut microbiota and host health, with significant implications for digestive disease management. Targeting BSH may offer new avenues for therapeutic interventions.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Bile acids and bile acid modification in health and disease: from novel modifications to therapeutic interventions
  2. Journal of Gastroenterology, 2019 -- Modifying Gut Microbiota to Improve Immune Regulation in the Treatment of Inflammatory Bowel Diseases
  3. Journal of Gastroenterology, 2019 -- The Role of the Gut Microbiome in Non-Alcoholic Fatty Liver Disease: Insights into Mechanisms and Treatment Options
  4. Gastroenterology 2024;166:409–434 -- AGA Guidelines on fecal microbiota-based therapies
  5. Journal of Gastroenterology — The Role of Immunoglobulin A in Hepatic Disorders
  6. Gastroenterology 2024;166:409–434
  7. Advances in the pathophysiology, diagnosis and management of chronic diarrhoea from bile acid malabsorption: a systematic review - PubMed
  8. New insights into microbial bile salt hydrolases: from physiological roles to potential applications - PubMed

Original Source(s)

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease

  • by Haitao Chu, Xin Song, Chang Liu, Tianjiao Ma, Wanlin Cui

  • June 9, 2026

Related Content

Leveraging Text Messaging and Behavior Theory to Improve Colorectal Cancer Screening in Federally Qualified Health Centers: Cohort Study

Gut decisions based on the liver: prediction of colorectal neoplasia using AI-based liver analysis of routine CT scans

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease